Meet the lab’s two new members

Our lab is growing! We are excited to introduce two new members who have joined the Lochmüller lab this winter.

Daniel O’Neil

Daniel holds a BSc in Biochemistry from the University of Ottawa. During his undergraduate studies, he worked with Dr. Alexandre Blais’s laboratory where he studied the role of the Six1 transcription factor in adult satellite cell proliferation. Subsequently, he completed his MSc in Neuroscience at the University of Ottawa in Dr. Ruth Slack’s laboratory. His thesis examined the role of the activator E2f transcription factors, crucial regulators of cell cycle progression, in adult neural stem cell quiescence and activation.

Daniel looks forward to applying his accumulated technical knowledge to support ongoing research projects in Dr. Lochmüller’s lab.

 

Catherine Choueiri

Catherine recently graduated with an HBSc degree in Biology from Western University in October 2020. After completing her final year, she worked as a research assistant and laboratory manager in Dr. Kathleen Hill’s lab. In her role, she contributed to projects relevant to environmental mutagenesis, mouse SNP genotyping, and the use of genomic signatures for disease screening. Under Kathleen Hill’s supervision, Catherine also completed a teaching fellowship at Western, during which she helped to redesign the Principles of Human Genetics course for online delivery.

In January 2021, Catherine began her Master’s program in Cellular and Molecular Medicine with a specialization in Human and Molecular Genetics. She is working under the supervision of Dr. Lochmüller to create a zebrafish model for riboflavin transporter deficiency to be used in therapeutic screening.

 

 

Neuromuscular junction and animal models

Read next...

haleyozgefinal

Two Research Lab Members Receive CIHR Funding Awards!

We are excited to share that two of our research team members have received competitive funding awards from the Canadian Institutes of Health Research (CIHR)...
Hanns CRC image (1)

Dr. Hanns Lochmüller’s Canada Research Chair Renewed Through 2032

We are pleased to announce that Dr. Hanns Lochmüller’s Tier 1 Canada Research Chair (CRC) in Neuromuscular Genomics and Health has been renewed through the...
kiran scientist

Dr. Kiran Polavarapu Appointed Scientist at the CHEO Research Institute

We are delighted to congratulate Dr. Kiran Polavarapu on his appointment as Scientist at the Children’s Hospital of Eastern Ontario Research Institute (CHEO RI). This...
welcome

Meet The Lab’s New Clinical Members!

Our research team is growing! We are excited to announce three new research staff who have joined the lab this winter, as well as two...
researcher of the year 2025

Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine

We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
Holland study

New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice

Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...